Jim Hollingshead

Jim Hollingshead is a seasoned executive with extensive leadership experience in the medical device industry. Currently serving as a Board Member and Audit Committee Member at Vantive since February 2025, Jim previously held the position of President and CEO at Insulet Corporation from July 2019 to May 2025, where leadership resulted in the successful global launch of the groundbreaking Omnipod 5 product and a significant increase in revenue and market position. Additionally, Jim has contributed as an Independent Director at AdvaMed and as a Board Member for the Medical Device Innovation Consortium and ResMed. At ResMed, Jim oversaw various roles, including President of the Sleep & Respiratory Care Business, driving innovation and substantial growth in the company's core divisions and product lines. Jim holds a BA in History and International Relations from Stanford University and both an MA and PhD in Political Science from the University of California, Berkeley.